Insider track record
OtherAcross 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Grimaud Brett A.. Officer active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 13 reports have been recorded. Activity tracked since 20 February 2023. The latest transaction was filed on 20 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
9,743 shares@ US$9.458.5% of flowOrdinary SharesSEC:0001415889-25-014259:0
75,000 shares0Ordinary SharesSEC:0001415889-25-006670:0
14,534 shares@ US$9.6614.0% of flowOrdinary SharesSEC:0001415889-25-005349:0
9,268 shares@ US$9.979.0% of flowOrdinary SharesSEC:0001415889-24-027567:0
9,268 shares@ US$8.227.1% of flowOrdinary SharesSEC:0001415889-24-022086:0
9,268 shares@ US$9.108.1% of flowOrdinary SharesSEC:0001415889-24-014135:0
100,000 shares0Ordinary SharesSEC:0001415889-24-010322:0
17,595 shares@ US$8.9215.1% of flowOrdinary SharesSEC:0001415889-24-004962:0
7,363 shares@ US$10.377.3% of flowOrdinary SharesSEC:0001415889-23-015450:0
8,912 shares@ US$9.708.2% of flowOrdinary SharesSEC:0001415889-23-012517:0
11,469 shares@ US$11.2112.4% of flowOrdinary SharesSEC:0001415889-23-008672:0
75,000 shares0Ordinary SharesSEC:0001415889-23-004273:0
10,198 shares@ US$10.4410.3% of flowOrdinary SharesSEC:0001415889-23-003071:0